Gene-repaired iPS cells as novel approach for patient with osteogenesis imperfecta

Introduction: The benefits of patient’s specific cell/gene therapy have been reported in relation to numerous genetic related disorders including osteogenesis imperfecta (OI). In osteogenesis imperfecta particularly also a drug therapy based on the administration of bisphosphonates partially helped...

Descripción completa

Detalles Bibliográficos
Autores principales: Fus-Kujawa, Agnieszka, Mendrek, Barbara, Bajdak-Rusinek, Karolina, Diak, Natalia, Strzelec, Karolina, Gutmajster, Ewa, Janelt, Kamil, Kowalczuk, Agnieszka, Trybus, Anna, Rozwadowska, Patrycja, Wojakowski, Wojciech, Gawron, Katarzyna, Sieroń, Aleksander L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348904/
https://www.ncbi.nlm.nih.gov/pubmed/37456734
http://dx.doi.org/10.3389/fbioe.2023.1205122

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10348904/
https://www.ncbi.nlm.nih.gov/pubmed/37456734
http://dx.doi.org/10.3389/fbioe.2023.1205122

Ejemplares similares